In tumor-bearing mice, stronger tumor remission was observed with PD-1Ab21 treatment than that with the combination of PD-1 blockade and IL-21 infusion, which was attributed to the increased frequency of TSCM cells and robust expansion of tumor-specific CD8(+) T cells with a memory phenotype. Here, CD8A is linked to neoplasm.